Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.76 |
| ▸ | MAPT | P10636 | 6/20 | 0.76 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.76 |
| ▸ | TSHR | P16473 | 5/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.76 |
| ▸ | HPGD | P15428 | 3/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.76 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.76 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.76 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10885876 | 0.90 | CACNA1D (0.60) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL1172946 | 0.87 | ADORA3 (1.00) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL29349595 | 0.87 | ADORA3 (1.00) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL3968 | 0.87 | ADORA3 (1.00) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL3858071 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL8851397 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL5694031 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL8851402 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL27076589 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR | |
| Nifedipine SCHEMBL27076587 | 0.86 | ADORA3 (0.97) | ADORA3CYP1A2MAPTCACNA1CTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0301133-A2 | Long acting formulation | SYNTEX (U.S.A.) INC. (US) | 1989-02-01 | — | — | EP | claimed |
| EP-0124777-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-10-29 | — | — | EP | claimed |
| US-4529733-A | Substituted in position 4 with a 2-nitrophenyl compound | MERRELL DOW PHARMACEUTICALS INC. (US) | 1985-07-16 | — | — | US | claimed |
| EP-0124777-A1 | 1,4-Dihydropyridine derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1984-11-14 | — | — | EP | claimed |
| US-5209933-A | A dihydropyridine compound | SYNTEX (U.S.A.) INC. (US) | 1993-05-11 | — | — | US | disclosed |
| US-5198226-A | Sustained release | SYNTEX (U.S.A.) INC. (US) | 1993-03-30 | — | — | US | disclosed |
| US-4940556-A | SUSTAINED RELEASE OF CALCIUM CHANNEL BLOCKERS | SYNTEX (U.S.A.) INC. (US) | 1990-07-10 | — | — | US | disclosed |
| EP-0301133-A2 | Long acting formulation | SYNTEX (U.S.A.) INC. (US) | 1989-02-01 | — | — | EP | disclosed |
| EP-0124777-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4529733-A | Substituted in position 4 with a 2-nitrophenyl compound | MERRELL DOW PHARMACEUTICALS INC. (US) | 1985-07-16 | — | — | US | disclosed |
| EP-0124777-A1 | 1,4-Dihydropyridine derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1984-11-14 | — | — | EP | disclosed |